The Biotinylated Anti-CD123 Antibody (HDLA007) is a powerful tool for researchers investigating the CD123 protein, a cell surface marker associated with hematopoietic stem cells and leukemia cells. This antibody, produced using innovative technology, has high specificity for human CD123 and is validated for use in multiple applications such as immunofluorescence, flow cytometry, and immunohistochemistry.CD123, also known as interleukin-3 receptor alpha chain, plays a crucial role in the development and function of various immune cells, particularly in the context of leukemias and other hematological disorders.
By targeting CD123, researchers can gain insights into the biology of these diseases and potentially develop new therapeutic strategies.The Biotinylated Anti-CD123 Antibody is a valuable tool for studies in immunology, oncology, and stem cell biology. Its ability to specifically bind to CD123 and facilitate detection and analysis in various experimental settings makes it a versatile asset for research laboratories focused on understanding the role of CD123 in health and disease.
Purified from cell culture supernatant by affinity chromatography
Formulation:
Powder
Buffer:
1XPBS
Storage:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Usage:
Research use only
Background:
Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-ㄐ窏ㄐ窏ㄐ窏_x0001_
